HRA® offers compensation of $500 to advanced practiced providers for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.

Please note: this is a non-CME, independently produced program. All content is developed by the HCPLive® team.

OVERVIEW

HCPLive® Clinical Forum are regional roundtable discussions where an expert moderator has the opportunity to directly engage with health care professionals (HCPs) to present data, medical advances, and patient case scenarios. This leads to a moderated forum between attendees to gather insights on their community practice implementation of new science, feedback on case scenarios, as well as other information which impact the clinical decision making of local HCPs.

These forums serve as a platform for localized education and peer-to-peer collaborative discussions aiming to ultimately elevate and improve patient care. 

LEARNING OBJECTIVES

• Examine the role of the OX40L/OX40R signaling pathway in atopic dermatitis pathogenesis and its potential to inform long-term disease control strategies.
• Evaluate clinical data and safety findings for emerging OX40L- and OX40R-targeted agents, including efficacy outcomes and durability of response.
• Discuss the potential place for OX40L- and OX40R-targeted therapies in the current atopic dermatitis treatment paradigm.

This event is held in partnership with Healthcare Research & Analytics (HRA®) to gain valuable insights into health care professional’s educational needs in their current practice setting.   

HRA® offers compensation of $500 to advanced practiced providers for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.

Copyright HCPLive 2025.

All Rights Reserved.

Terms & Conditions

Privacy Policy

Contact Us: events@hcplive.com